Abliva AB (publ)
Abliva AB (publ) (NEVPF) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Abliva AB (publ) (NEVPF), covering cash flow, earnings, and balance sheets.
Abliva AB (publ) (NEVPF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Abliva AB (publ) NEVPF financial performance.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $490000.00 | $485000.00 |
| Gross Profit | $0.00 | $0.00 | -$490000.00 | -$485000.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $0.00 | $0.00 | $13.76M | $11.60M |
| SG&A Expenses | $0.00 | $0.00 | $11.17M | $6.92M |
| Operating Expenses | $27.24M | $19.86M | $24.92M | $18.52M |
| Total Costs & Expenses | $27.24M | $19.86M | $25.41M | $19.008M |
| Interest Income | $583000.00 | $332000.00 | $1000.00 | $1000.00 |
| Interest Expense | $10000.00 | $12000.00 | $13000.00 | $14000.00 |
| Depreciation & Amortization | $470000.00 | $474000.00 | $490000.00 | $485000.00 |
| EBITDA | -$26.00M | -$19.05M | -$25.25M | -$17.68M |
| EBITDA Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$27.24M | -$19.86M | -$25.74M | -$19.008M |
| Operating Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | $765000.00 | $320000.00 | -$12000.00 | -$13000.00 |
| Income Before Tax | -$26.48M | -$19.54M | -$25.75M | -$18.18M |
| Income Before Tax Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $1000.00 |
| Net Income | -$26.48M | -$19.54M | -$25.75M | -$18.18M |
| Net Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS | -$0.02 | -$0.02 | -$0.02 | -$0.02 |
| Diluted EPS | -$0.02 | -$0.02 | -$0.02 | -$0.02 |
| Weighted Avg Shares Outstanding | $1.54B | $1.26B | $1.26B | $1.06B |
| Weighted Avg Shares Outstanding (Diluted) | $1.54B | $1.26B | $1.26B | $1.06B |
Over the last four quarters, Abliva AB (publ)'s revenue moved from $0.00 in Q1 2024 to $0.00 in Q4 2024. Operating income in Q4 2024 was -$27.24M, with a strong operating margin of N/A. Despite fluctuations in R&D and SG&A expenses, EBITDA for Abliva AB (publ) remained robust at -$26.00M, reflecting operational efficiency. Net income dropped to -$26.48M, with an EPS of -$0.02. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan